Clear answers when performance in cardiometabolic markets is at risk

We partner with commercial leaders to understand the patient behaviors driving or blocking brand performance across diabetes, obesity, and related cardiometabolic conditions.  By combining direct access to relevant patients, deep category experience, and rigorous research design, we deliver trustworthy patient answers in as little as two weeks so teams can move forward with confidence.

Built for commercial leaders accountable for performance

We partner with director-level and above commercial brand and portfolio leaders in pharma who are responsible for brand performance, product adoption, and long-term retention across diabetes, obesity, and related cardiometabolic categories.

When performance data raises questions but doesn’t provide answers, we help close the gap, giving teams the patient clarity they need to move forward with confidence.

Reducing the burden from question to answer

We help commercial teams get clear patient answers to questions like:

• Why isn’t adoption increasing despite strong awareness?
• What’s driving early drop-off or poor persistence?
• Which patient segments are most likely to respond, and why?
• How should messaging, channels, or support evolve to change behavior?
• How will future changes in the market impact product retention?

Performance data shows what's happening. Patients explain why.

Claims data, dashboards, and campaign metrics can highlight performance gaps, but rarely explain the underlying drivers of patient behavior.

In cardiometabolic markets, decisions are shaped by lived experience, comorbidities, access barriers, stigma, and long-term behavior change. Without direct patient access, teams are often left guessing which levers will actually influence adoption and persistence.

That uncertainty slows decisions and increases risk.

A consultative approach designed to deliver real answers

We help pharma teams uncover what’s actually driving patient adoption, persistence, and drop-off across diabetes, obesity, and related cardiometabolic conditions.

Rather than offering a one-size-fits-all platform, we apply the right mix of research methods, technology, and patient access to answer your most important commercial questions, quickly and rigorously.

Deep cardiometabolic expertise. Proven results.

Speed with rigor

We deliver fast answers without compromising research quality.

Unmatched cardiometabolic experience

Thrivable has delivered 750+ projects across diabetes and obesity.

Built-in patient access

Built on access to a large, engaged, vetted patient population across diabetes, obesity, and other cardiometabolic conditions, so teams can trust they’re hearing from the right patients.

  Low-risk partner

Seven years of delivery and a 75+ NPS reflect the trust teams place in our work.

Answers designed to drive commercial impact

Every engagement is designed to help teams improve product adoption, increase patient retention, optimize brand performance, and drive stronger Rx lift and ROI.

We focus on answers that change decisions, not reports that sit on a shelf.